Genocea Biosciences reported $-15978000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agenus AGEN:US USD -54222000 7.79M
Baxter International BAX:US USD -2937000000 3.19B
Bluebird Bio BLUE:US USD -76520000 23.62M
Cytokinetics CYTK:US USD -142310000 122.49M
Cytori Therapeutics CYTX:US USD -5219000 63K
Genocea Biosciences GNCA:US USD -15978000 2.7M
Glaxosmithkline GSK:US GBP 10.32B 9.48B
Infinity Pharmaceuticals INFI:US USD -10717000 1.27M
Merk MRK:US USD 3.25B 696M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Moderna Inc MRNA:US USD 1.04B 1.15B
Pfizer PFE:US USD 8.61B 1.3B